SI-BONE Inc
Troy S. Wahlenmaier has served as the Vice President of U.S. Sales since January 2018. Mr. Wahlenmaier joined in February 2012, serving in sales management positions and earning promotions to Western Area Director of Sales in July 2014 and Senior Director of National Sales in July 2016. Mr. Wahlenmaier has over 28 years of experience in the medical device industry, focused on innovative minimally invasive technologies. Prior to joining SI BONE, Mr. Wahlenmaier served as Director of Sales with NuVasive, 2006-2010. Mr. Wahlenmaier has been in sales leadership positions within the spine industry since 1996 serving at Sulzer Spine-Tech, Inc. from 1996-1999 and Kyphon, 1999-2005. Mr. Wahlenmaier began his medical device career in 1990 with United States Surgical Corporation, an innovator in minimally invasive surgery. Mr. Wahlenmaier received a B.A. in Business Administration from Wichita State University in 1990.
This person is not in any offices
SI-BONE Inc
2 followers
SI-BONE, Inc. is focused on development of medical devices. The Company is engaged in the development, manufacture and commercialization of minimally invasive surgical devices for the treatment of patients with low back symptoms related to certain sacroiliac (SI) joint disorders. The Company offers iFuse Implant System, which provides a minimally invasive surgical solution to fuse the SI joint using patented triangular titanium implants that create an interference fit within the ilium and sacrum. The triangular implant shape, combined with the press fit insertion, is designed to provide fixation by minimizing rotational motion. The implants has a porous surface that provide an environment for bone ongrowth and ingrowth, facilitating long-term fusion of the joint. The iFuse Implant System is intended for sacroiliac fusion for conditions, including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis.